AFIB Ablation denied as experimental or investigational by Humana?

Humana's specific coverage criteria for afib ablation are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Denied Catheter Ablation for AFib as Experimental

Humana's experimental or investigational denial means the plan has determined — under its own coverage policy — that catheter ablation for atrial fibrillation lacks sufficient evidence of clinical effectiveness to qualify as a covered benefit. This type of denial is almost always worth challenging, because catheter ablation for AFib has been performed for decades, is included in major cardiology society guidelines, and is recognized by the FDA as a lawful medical device-based procedure. The critical task in your appeal is demonstrating that established clinical consensus — not just emerging opinion — supports ablation for a patient with your specific clinical profile.

## Why This Denial Is Appealable

Insurers must use current, evidence-based coverage criteria. If Humana's determination relies on outdated policy language that has not been updated to reflect contemporary guideline recommendations from the Heart Rhythm Society (HRS), the American College of Cardiology (ACC), or the American Heart Association (AHA), that is a challengeable basis for denial. An independent reviewer is not bound by Humana's internal coverage policy — they assess whether the denial is consistent with generally accepted standards of medical practice. For catheter ablation in symptomatic AFib, particularly after antiarrhythmic drug failure, those standards are well established.

## Federal Appeal Rights

• Internal Appeal: File a written appeal with Humana within the deadline on your denial letter. Request the full clinical rationale and the specific policy criteria used to classify ablation as experimental.
• External Review (ACA §2719): Experimental/investigational denials are a primary category for external review by an Independent Review Organization (IRO). The IRO applies current medical evidence and professional standards — not the plan's internal policy — to assess whether ablation is experimental in your case. You generally have up to four months from the adverse benefit determination to request external review. Expedited external review is available if waiting for a standard timeline would seriously jeopardize your health.
• ERISA §503: Employer-plan members are entitled to receive the complete claim file, all internal guidelines applied, and a full-and-fair review of any adverse benefit determination.

## Documentation to Gather

• Cardiology and electrophysiology records confirming your AFib diagnosis, type (paroxysmal, persistent, long-standing), symptom burden, and duration
• History of prior antiarrhythmic medications tried, with start/stop dates and documented outcomes
• Your EP specialist's recommendation for ablation with a specific explanation of medical necessity in your clinical context
• A letter from your EP physician citing current professional society guidelines (by organization name, not by specific statistic) supporting ablation for patients with your profile
• Any peer-reviewed systematic reviews or professional society position statements your physician considers relevant (your doctor should curate these, not you)

## Criteria-Mapping Strategy

Obtain Humana's medical policy for catheter ablation. Identify each condition under which it considers ablation non-experimental or covered. Map your documented clinical situation to each condition:

| Humana Coverage Criterion | Your Clinical Evidence | |---|---| | AFib type and chronicity | [EP note confirming type, duration] | | Symptom severity | [Chart documentation of symptoms] | | Prior drug therapy failure | [Medication history with outcomes] | | Physician recommendation | [EP letter recommending ablation] |

An IRO reviewer will compare your situation to accepted medical standards independent of what Humana's policy says — make that comparison easy by organizing your evidence clearly.